An Umbrella Review on the Effectiveness of Systemic Treatments for the Management of Advanced Hepatocellular Carcinoma
Author(s)
Zile I1, Rabar S2, Bem D2
1Health Economics and Outcomes Research Ltd, Cardiff, UK, 2Health Economics and Outcomes Research Ltd, Cardiff, CRF, UK
Presentation Documents
OBJECTIVES: This umbrella review of systematic literature reviews (SLRs) and meta-analyses (MAs) aims to identify and synthesize currently available knowledge on the effectiveness of systemic treatments for advanced hepatocellular carcinoma (HCC). It addresses three research questions: (1) What is the clinical efficacy of systemic therapies used in patients with advanced HCC? (2) What are the most serious adverse events relating to those therapies? (3) What is the quality of the available evidence? METHODS: Comprehensive search strategies were designed for Ovid Medline, Ovid Embase, Cochrane Library, DARE and Epistimonikos using terms related to hepatocellular carcinoma, advanced disease stage and study design. Screening will be conducted by two independent reviewers with discrepancies resolved by discussion or the involvement of a third reviewer. SLRs and MAs deemed eligible for inclusion will be assessed for their methodological quality using the Assessment of Multiple Systematic Reviews (AMSTAR2) tool. The review protocol is registered with PROSPERO (CRD42021259210). RESULTS: Database searches were conducted from January 2011 until May 2021 and resulted in 1,699 publications. Study selection is in progress including SLRs and MAs of randomised controlled trials examining systemic treatments (alone or in combination with other systemic or locoregional therapies) for adults diagnosed with advanced HCC. SLRs assessing locoregional, adjuvant and neoadjuvant therapies, surgical procedures and liver transplantation, as well as SLRs and MAs of real-world studies are excluded. Outcomes of interest include overall survival, response rate and serious adverse events. Study findings will be qualitatively summarised in a narrative synthesis with key results presented in tables and/or graphs. Overlaps of original research studies in the included SLRs and MAs will be presented. CONCLUSIONS: This umbrella review will summarise the effectiveness of currently available systemic treatments for advanced HCC. It will also identify possible gaps in the literature and provide recommendations for future research in advanced HCC.
Conference/Value in Health Info
2021-11, ISPOR Europe 2021, Copenhagen, Denmark
Value in Health, Volume 24, Issue 12, S2 (December 2021)
Code
POSA16
Topic
Clinical Outcomes
Topic Subcategory
Comparative Effectiveness or Efficacy
Disease
Oncology